Brain Structure Complexity Predicts Deep Brain Stimulation Outcomes in Parkinson's Disease
Author Information
Author(s): Schoen Devin, Deutsch Skyler, Mehta Juhi, Wang Sarah, Kornak John, Starr Philip, Wang Doris, Ostrem Jill, Bledsoe Ian, Morrison Melanie
Primary Institution: University of California - San Francisco
Hypothesis
Can measures of brain structure complexity predict changes in Parkinson's disease medications after deep brain stimulation?
Conclusion
The study found that brain structure complexity is a useful predictor of medication changes following deep brain stimulation in Parkinson's disease patients.
Supporting Evidence
- Fractal dimension was validated as a biomarker of Parkinson's disease progression.
- Adding imaging features improved the predictive model's accuracy significantly.
- FD features explained an additional 13.6% of variance in medication outcomes.
Takeaway
Doctors can use brain scans to see how complex a person's brain structure is, which can help them decide if deep brain stimulation will work for that person.
Methodology
The study used T1-weighted MRI data to extract measures of fractal dimension from the brains of 231 Parkinson's disease patients and analyzed their relationship with medication changes after deep brain stimulation.
Potential Biases
Variability in clinical data due to different sites and protocols may introduce bias.
Limitations
The study relied on retrospective data and automated segmentation tools, which may not be as accurate as manual methods.
Participant Demographics
Mean age 65 years; 33% female; 80% received bilateral DBS implants.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website